These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33902837)

  • 1. Prevalence of SARS-Cov-2 Antibodies in Emergency Medicine Healthcare Workers.
    Wang RC; Murphy CE; Kornblith AE; Kurtz T; Kohn MA
    Ann Emerg Med; 2021 May; 77(5):556-557. PubMed ID: 33902837
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of SARS-CoV-2 antibodies in health care personnel of two acute care hospitals in Linz, Austria.
    Egger M; Bundschuh C; Wiesinger K; Bräutigam E; Berger T; Clodi M; Dieplinger B
    Clin Chem Lab Med; 2021 May; 59(6):e231-e234. PubMed ID: 33554543
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of SARS-CoV-2 antibodies in pediatric healthcare workers.
    Morris CR; Sullivan P; Mantus G; Sanchez T; Zlotorzynska M; Hanberry B; Iyer S; Heilman S; Camacho-Gonzalez A; Figueroa J; Manoranjithan S; Leake D; Mendis R; Cleeton R; Chen C; Krieger R; Bush P; Hughes T; Little WK; Suthar MS; Wrammert J; Vos MB
    Int J Infect Dis; 2021 Apr; 105():474-481. PubMed ID: 33722686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of SARS-CoV-2 Antibodies From a National Serosurveillance of Kenyan Blood Donors, January-March 2021.
    Uyoga S; Adetifa IMO; Otiende M; Yegon C; Agweyu A; Warimwe GM; Scott JAG
    JAMA; 2021 Oct; 326(14):1436-1438. PubMed ID: 34473191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 antibodies in healthcare workers in a large university hospital, Kerala, India.
    Kumar A; Sathyapalan D; Ramachandran A; Subhash K; Biswas L; Beena KV
    Clin Microbiol Infect; 2021 Mar; 27(3):481-483. PubMed ID: 32949718
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence and Time Trend of SARS-CoV-2 Infection in Puducherry, India, August-October 2020.
    Kar SS; Sarkar S; Murali S; Dhodapkar R; Joseph NM; Aggarwal R
    Emerg Infect Dis; 2021 Feb; 27(2):666-669. PubMed ID: 33496645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The seroprevalence of SARS-CoV-2 in a rural southwest community.
    Santarelli A; Lalitsasivimol D; Bartholomew N; Reid S; Reid J; Lyon C; Wells J; Ashurst J
    J Osteopath Med; 2021 Feb; 121(2):199-210. PubMed ID: 33567087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020.
    Shakiba M; Nazemipour M; Salari A; Mehrabian F; Nazari SSH; Rezvani SM; Ghasempour Z; Heidarzadeh A; Mansournia MA
    Emerg Infect Dis; 2021 Feb; 27(2):636-638. PubMed ID: 33349310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Anti-SARS-CoV-2 Specific Antibodies in Health-Care Workers Compared to General Population during an Early Phase of the Pandemic, Tehran-Iran.
    Mortezagholi S; Rostamzadeh D; Alinejad M; Younesi V; Tabarsi P; Shabani M
    Iran J Immunol; 2021 Mar; 18(1):82-92. PubMed ID: 33787517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and Clinical Characteristics of Emergency Department Patients with COVID-19 in a Rhode Island Healthcare System.
    Naganathan S; Paiva M; Soliman L; Amanullah S; Aluisio AR; Genisca AE
    R I Med J (2013); 2021 Jun; 104(5):24-29. PubMed ID: 34044433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal assessment of SARS-CoV-2 IgG seroconversionamong front-line healthcare workers during the first wave of the Covid-19 pandemic at a tertiary-care hospital in Chile.
    Iruretagoyena M; Vial MR; Spencer-Sandino M; Gaete P; Peters A; Delgado I; Perez I; Calderon C; Porte L; Legarraga P; Anderson A; Aguilera X; Vial P; Weitzel T; Munita JM
    BMC Infect Dis; 2021 May; 21(1):478. PubMed ID: 34039287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe acute respiratory syndrome coronavirus 2 antibodies in pregnant women admitted to labor and delivery units.
    Haizler-Cohen L; Davidov A; Blitz MJ; Fruhman G
    Am J Obstet Gynecol; 2021 Jan; 224(1):112-114. PubMed ID: 32971014
    [No Abstract]   [Full Text] [Related]  

  • 13. Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure.
    Hunter BR; Dbeibo L; Weaver CS; Beeler C; Saysana M; Zimmerman MK; Weaver L
    Infect Control Hosp Epidemiol; 2020 Dec; 41(12):1441-1442. PubMed ID: 32741406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated SARS-CoV-2 Seroprevalence Among Persons Aged <18 Years - Mississippi, May-September 2020.
    Hobbs CV; Drobeniuc J; Kittle T; Williams J; Byers P; Satheshkumar PS; Inagaki K; Stephenson M; Kim SS; Patel MM; Flannery B;
    MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(9):312-315. PubMed ID: 33661862
    [No Abstract]   [Full Text] [Related]  

  • 15. Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.
    Brandstetter S; Roth S; Harner S; Buntrock-Döpke H; Toncheva AA; Borchers N; Gruber R; Ambrosch A; Kabesch M
    Pediatr Allergy Immunol; 2020 Oct; 31(7):841-847. PubMed ID: 32413201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients.
    Del Zompo F; De Maio F; Santopaolo F; Ricci R; Gasbarrini A; Pompili M; Ponziani FR
    Dig Liver Dis; 2021 May; 53(5):541-544. PubMed ID: 33707148
    [No Abstract]   [Full Text] [Related]  

  • 17. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States.
    Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
    PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-sectional pilot study exploring the feasibility of a rapid SARS-CoV-2 immunization test in health and nonhealthcare workers.
    Escribese MM; Nistal-Villan E; Fernandez P; Rico P; Martin-Antoniano IA; de la Cuerda A; Chivato T; Barber D
    Allergy; 2021 Mar; 76(3):896-899. PubMed ID: 32754925
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence of SARS-CoV-2-Specific Antibodies, Japan, June 2020.
    Yoshiyama T; Saito Y; Masuda K; Nakanishi Y; Kido Y; Uchimura K; Mitarai S; Suzuki T; Nakagama Y; Kubota H; Satomi M; Uchikoba S; Ohnishi M; Wakita T; Kato S; Kato K
    Emerg Infect Dis; 2021 Feb; 27(2):628-631. PubMed ID: 33496235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 seroprevalence in healthcare workers in a high-volume ophthalmology centre in Guatemala.
    Davila-Siliezar P; Wer A; Barnoya J
    Ann Med; 2021 Dec; 53(1):1956-1959. PubMed ID: 34727801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.